Older studies had shown that long-term exposure to PPARα agonists in rodents led to HCC, but this was likely due to chronic oxidative stress and resulting inflammation rather than a direct effect of PPARα [44]. The gene discussed is PPARA; the disease is hepatocellular carcinoma.